Position in SRRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,178,580
-$700,806 QoQ
Shares Held
94,156
-21.3% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 304 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. SRRK ranks #78 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in SRRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,178,580 | 94,156 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,879,386 | 119,597 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,632,449 | 82,462 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,538,686 | 68,171 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,194,763 | 61,964 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,766,223 | 54,937 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $13,491,595 | 312,161 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $179,526 | 22,413 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $183,341 | 22,010 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,714,512 | 96,538 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,772,294 | 307,037 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $103,397 | 14,563 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $93,811 | 12,442 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,696,824 | 212,103 | Shares | Defined | 2023-05-12 | |
| 2022-03-31 | $153,286 | 11,892 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $290,030 | 11,676 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $422,424 | 12,793 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $314,720 | 10,890 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $6,952,932 | 137,247 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $239,786 | 4,941 | Shares | Defined | 2021-02-16 | |
| 2020-03-31 | $451,702 | 37,300 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||